Use of classifiers to optimise the identification and characterisation of metastatic breast cancer in a nationwide administrative registry

Author:

Valachis Antonis1ORCID,Carlqvist Peter2,Szilcz Máté34,Freilich Jonatan3,Vertuani Simona5ORCID,Holm Barbro5,Lindman Henrik6

Affiliation:

1. Department of Oncology, Faculty of Medicine and Health, Örebro University Hospital, Örebro, Sweden

2. Nordic Market Access AB, Stockholm, Sweden

3. Parexel International, Stockholm, Sweden

4. Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden

5. Novartis Sverige AB, Kista, Sweden

6. Department of Immunology, Genetics and Pathology, Experimental and Clinical Oncology; Clinical Oncology, Faculty of Medicine, Uppsala University Hospital, Uppsala, Sweden

Publisher

Informa UK Limited

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology,General Medicine

Reference27 articles.

1. Ferlay J, Ervik M, Lam F, et al. Global Cancer Observatory: Cancer Today. Lyon, France: International Agency for Research on Cancer 2018. [cited 2020 June 15]. Available from: https://gco.iarc.fr/today

2. SEER. Cancer Stat Facts: Female Breast Cancer 2020 [cited 2020 July 03]. Available from: https://seer.cancer.gov/statfacts/html/breast.html.

3. Trends in the survival of patients diagnosed with breast cancer in the Nordic countries 1964–2003 followed up to the end of 2006

4. Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

5. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3